Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Current Leases: 2020-2024

Historic Current Leases for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Dec 2024 value amounting to $1.7 million.

  • Mirum Pharmaceuticals' Current Leases rose 54.80% to $1.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.7 million, marking a year-over-year increase of 54.80%. This contributed to the annual value of $1.7 million for FY2024, which is 54.80% up from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Current Leases stood at $1.7 million for FY2024, which was up 54.80% from $1.1 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Current Leases registered a high of $1.7 million during FY2024, and its lowest value of $636,000 during FY2020.
  • In the last 3 years, Mirum Pharmaceuticals' Current Leases had a median value of $1.1 million in 2023 and averaged $1.2 million.
  • Data for Mirum Pharmaceuticals' Current Leases shows a peak YoY soared of 54.80% (in 2024) over the last 5 years.
  • Over the past 5 years, Mirum Pharmaceuticals' Current Leases (Yearly) stood at $636,000 in 2020, then grew by 11.79% to $711,000 in 2021, then spiked by 30.94% to $931,000 in 2022, then grew by 18.58% to $1.1 million in 2023, then skyrocketed by 54.80% to $1.7 million in 2024.